Roche Pharma launches multiple sclerosis treatment drug in India

The company has introduced Ocrevus (Ocrelizumab) which is the first and only approved disease modifying therapy for both Relapsing Remitting Multiple Sclerosis (RRMS) and Primary Progressive Multiple Sclerosis (PPMS).
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news